InterMune Partners With Roche
InterMune Inc. (ITMN) will partner with Roche Group Ltd. to develop its hepatitis C treatment. Shares of InterMune jumped $4.29 to close at $21.12.
posted by FC Market News at 2:50 PM
Tuesday, October 17, 2006
Previous Posts
- Sales Rise For Eaton
- Greenbrier To Acquire Meridian Rail
- Lumera's Test Successful
- Evergreen Solar Lands $100M Deal
- Open Solutions To Go Private
- Strong Sales Lift Mattel's Earnings
- La-Z-Boy Lowers Guidance
- Centex Warns Of Shortfall
- Saifun Loses Licensing Fees
- EHealth Surges In Market Debut
0 Comments:
Post a Comment
<< Home